PhaseRx (PZRXQ) Stock Price, News & Analysis

Company Overview

PhaseRx Inc. is a clinical-stage biopharmaceutical company focused on the development of orally administered protein therapeutics for gastrointestinal and liver-related disorders. Founded to address limitations in current enzyme and peptide delivery methods, the company’s proprietary platform leverages engineered bacterial spores to transport and release therapeutic proteins directly to the intestinal tract. PhaseRx’s technology aims to improve patient convenience and compliance by enabling oral dosing of molecules that traditionally require injection or infusion.

The company’s lead product candidate targets hyperammonemia and urea cycle disorders, rare genetic conditions characterized by elevated ammonia levels that can cause serious neurological and metabolic complications. In preclinical studies, PhaseRx’s spore-based formulation demonstrated the ability to degrade excess ammonia in the gut before it enters the bloodstream. Additional pipeline programs are exploring the use of the same delivery platform for other metabolic and inflammatory conditions affecting the gastrointestinal system.

PhaseRx is headquartered in Massachusetts and operates under regulatory oversight to advance its clinical pipeline. The company collaborates with academic institutions and contract research organizations to conduct preclinical research and early-stage human trials. As a dedicated developer of oral biologics, PhaseRx seeks to expand the reach of protein-based therapies beyond traditional administration routes, with the goal of improving quality of life for patients with rare and chronic gastrointestinal diseases.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PZRXQ Stock Analysis - Frequently Asked Questions

How do I buy shares of PhaseRx?

Shares of PZRXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:PZRXQ
• CIK: N/A
• Web: www.phaserx.com
• Phone: (206) 805-6300
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 1.55